Home Cart 0 Sign in  
X

[ CAS No. 17435-72-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 17435-72-2
Chemical Structure| 17435-72-2
Chemical Structure| 17435-72-2
Structure of 17435-72-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 17435-72-2 ]

Related Doc. of [ 17435-72-2 ]

Alternatived Products of [ 17435-72-2 ]

Product Details of [ 17435-72-2 ]

CAS No. :17435-72-2 MDL No. :MFCD00031518
Formula : C6H9BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :MTCMFVTVXAOHNQ-UHFFFAOYSA-N
M.W : 193.04 Pubchem ID :310620
Synonyms :

Calculated chemistry of [ 17435-72-2 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.5
Num. rotatable bonds : 4
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 39.64
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.31 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.25
Log Po/w (XLOGP3) : 1.64
Log Po/w (WLOGP) : 1.5
Log Po/w (MLOGP) : 1.69
Log Po/w (SILICOS-IT) : 1.57
Consensus Log Po/w : 1.73

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.81
Solubility : 3.02 mg/ml ; 0.0156 mol/l
Class : Very soluble
Log S (Ali) : -1.81
Solubility : 3.02 mg/ml ; 0.0157 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.07
Solubility : 1.65 mg/ml ; 0.00855 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.24

Safety of [ 17435-72-2 ]

Signal Word:Danger Class:8
Precautionary Statements:P210-P264-P271-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P370+P378-P403+P233-P501 UN#:3265
Hazard Statements:H227-H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 17435-72-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 17435-72-2 ]
  • Downstream synthetic route of [ 17435-72-2 ]

[ 17435-72-2 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 10029-04-6 ]
  • [ 17435-72-2 ]
YieldReaction ConditionsOperation in experiment
82% With phosphorus tribromide In diethyl ether at 0 - 20℃; for 3 h; To a stirred solution of ethyl 2-(hydroxyl-methyl)acrylate (2 g, 15.4 mmol) in diethyl ether (15 mL), at0 °C phosphorus tribromide (0.51 mL, 5.4 mmol) wasadded dropwise. The reaction mixture was stirred for3 h from 0 °C to room temperature. Water (5 mL) wasadded and the product was extracted with hexanes (3x 10 mL). The combined organic layers was washed with brine (2 x 10 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to give 2-(bromomethyl)propenoicacid ethyl ester 14 (2.4 g, 12.3 mmol, 82 percent) as a colourless liquid which was used in the next step without further purification. Colourless oil; 1H NMR (400 MHz, CDCI3) O 1.30 (t, J=7.2 Hz, 3H, H6), 4.16 (5, 2H, H4), 4.24 (q, J=7.0 Hz, 2H, H5), 5.92 (5, 1H, Hi’), 6.30 (5, iH, Hi), 13C NMR (101 MHz, CDCI3) O 14.1 (CH3, C6), 29.3 (CH2, C4), 61.2 (CH2, CS), 128.8 (CH2, Ci), 137.6 (C, C2), 164.8 (C, C3), IR (vmaxcm1) 1718 (C=O ester), 1628 (C=Calkene), 1182 (C—C ester), 523 (C—Br), HRMS-El: m/z [M+H] Calcd for C6H10BrO2:Expected: 192.9864. Found: 192.6870.
70% With phosphorus tribromide In diethyl ether at -10 - 20℃; for 3 h; To the mixture of ethyl 2-(hydroxymethyl) acrylate (4 g, 0.030 mol) anddry ethyl ether (20 mL), phosphorus tribromide (1.4 mL, 0.015 mol) was added dropwise at –10 oC while stirring. After addition was completed thesolution was stirred at room temperature for 3 h. Water (20 mL) was added at–10 oC and the mixture was extracted with hexane (3X 10 ml) andwashed with a saturated solution of sodium chloride (2X 10 mL). After dryingthe organic layer over magnesium sulfate, the solvent was evaporated underreduced pressure and the crude product 7(4.7 g) was purified using vacuum distillation; Product yield: 4.1 g (70 percent);b.p. 54-58 oC/ 2 torr. Purity was confirmed using 1H NMRanalysis. 1H NMR: (400 MHz, CDCl3), 6.22 (1 H, s), 5.87 (1H, s), 4.22 (2 H, s), 4.24 (2 H, q), 1.31 (3 H, t)
56.6% With phosphorus tribromide In diethyl ether at -10 - 20℃; for 3 h; Phosphorus tribromide (17.16 g, 63.41 MMOL) was added to a stirred solution of the compound of example 30 (17.92 g, 138.1 MMOL) in dry ether (132 mL) at-10 °C. The temperature was allowed to rise to 20 °C and stirring was continued for 3h. Water (80 mL) was then added at-10 °C and the mixture was extracted with hexane (3 x 45 mL). The organic extracts were washed with saturated sodium chloride solution (2 x 45 mL) and dried with anhydrous MGS04. Evaporation of solvent under vacuum gave 15.07 g (yield 56.6 percent) of the crude product, which was used directly in the next reaction without any further purification. 1H NMR (CDCI3, 400MHZ) 8 6.25 (s, 1H), 5.88 (s, 1H), 4.2 (q, 2H), 4.11 (s, 2H), 1.25 (t, 3H); 13C NMR (CDCI3, 400 MHz) 5 166. 7,140. 1,125. 3,61. 1, 53.9, 14.4
34% With sulfuric acid; hydrogen bromide In water at 12 - 26℃; for 24 h; EXAMPLE 4 Preparation of EBMA EHMA is dissolved in a mixture of 48percent aqueous hydrobromic acid and concentrated sulfuric acid and the mixture is stirred at 25° C. for 24 hours. The reaction mixture is then extracted with a water immiscible solvent (petroleum ether, hexane, heptane), the organic phase is washed with a dilute solution of sodium bicarbonate and the crude product is concentrated under vacuum to afford the compound of Formula II at a purity of >95percent. ; EXAMPLE 5 EHMA (27 kg, 207 moles) was charged to the reactor. HBr (48percent, 3.25 eq, 112 kg, 672 mol) was added and the mixture was then cooled to 12° C. At 12° C., sulfuric acid (2.0 eq, 39 kg, 398 mol) was added at such a rate that the internal temperature did not exceed 15° C. After all the acid was added, the mixture was left to stir at room temperature (22-26° C.) overnight. The reaction mixture was then extracted with hexane (3.x.33 kg). The hexane was pumped into the reactor, stirred for 30 minutes; allowed to settle for 30 minutes and then the phases separated. The hexane extract was washed with an aqueous sodium bicarbonate solution (5percent, 33 kg). The mixture was stirred for 30 minutes, and then the stirrer stopped for 30 minutes to allow the phases to separate. This process was repeated twice. The washed hexane extract was then transferred to the distillation column. The hexane was then distilled at 40° C. under reduced pressure. The temperature was increased to 50° C. to remove any water that might be present. The residue containing EBMA was then distilled under high vacuum pump (80° C./<1 mm Hg) to obtain a 98percent pure product (16.4 kg, 34percent).

Reference: [1] Journal of Polymer Science, Part A: Polymer Chemistry, 2011, vol. 49, # 6, p. 1513 - 1516
[2] Angewandte Chemie - International Edition, 2016, vol. 55, # 5, p. 1872 - 1875[3] Angew. Chem., 2016, vol. 128, # 5, p. 1904 - 1907,4
[4] Angewandte Chemie - International Edition, 2017, vol. 56, # 41, p. 12619 - 12623[5] Angew. Chem., 2017, vol. 129, # 41, p. 12793 - 12797,5
[6] Organic Letters, 2018, vol. 20, # 11, p. 3296 - 3299
[7] Synthesis, 1982, # 11, p. 924 - 926
[8] Tetrahedron Letters, 1994, vol. 35, # 9, p. 1371 - 1374
[9] Tetrahedron Letters, 1994, vol. 35, # 17, p. 2679 - 2682
[10] Journal of Organic Chemistry, 2012, vol. 77, # 22, p. 10010 - 10020
[11] Organic Syntheses, 1988, vol. 66, p. 220 - 220
[12] Patent: WO2017/51326, 2017, A1, . Location in patent: Page/Page column 43
[13] European Journal of Organic Chemistry, 2009, # 12, p. 1944 - 1960
[14] Tetrahedron Letters, 1998, vol. 39, # 24, p. 4163 - 4166
[15] Chemistry - A European Journal, 2018, vol. 24, # 37, p. 9269 - 9273
[16] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 18, p. 4995 - 5010
[17] Tetrahedron Letters, 2014, vol. 55, # 51, p. 7029 - 7033
[18] European Journal of Organic Chemistry, 2014, vol. 2014, # 3, p. 502 - 505
[19] Tetrahedron Asymmetry, 2013, vol. 24, # 7, p. 395 - 401
[20] Journal of the American Chemical Society, 2017, vol. 139, # 43, p. 15308 - 15311
[21] Patent: WO2004/50620, 2004, A2, . Location in patent: Page 47-48
[22] Patent: US2009/88577, 2009, A1, . Location in patent: Page/Page column 7-8; sheet 1; 3
[23] Phosphorus, Sulfur and Silicon and Related Elements, 1999, vol. 144-146, p. 133 - 136
[24] Patent: EP1681283, 2006, A1, . Location in patent: Page/Page column 5
[25] Organic and Biomolecular Chemistry, 2007, vol. 5, # 22, p. 3614 - 3622
[26] Organic Letters, 2009, vol. 11, # 20, p. 4560 - 4563
[27] Organic Process Research and Development, 2011, vol. 15, # 1, p. 249 - 257
[28] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 22, p. 5219 - 5223
[29] Organic Letters, 2017, vol. 19, # 4, p. 914 - 917
[30] Angewandte Chemie - International Edition, 2017, vol. 56, # 14, p. 3987 - 3991[31] Angew. Chem., 2017, vol. 129, # 14, p. 4045 - 4049,5
[32] Patent: US9682019, 2017, B2, . Location in patent: Page/Page column 23; 24
  • 2
  • [ 64-17-5 ]
  • [ 72707-66-5 ]
  • [ 17435-72-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1987, vol. 30, # 1, p. 165 - 168
[2] Archiv der Pharmazie, 1984, vol. 317, # 2, p. 176 - 183
[3] Organic Syntheses, 1983, vol. 61, p. 56 - 56
  • 3
  • [ 140-88-5 ]
  • [ 17435-72-2 ]
Reference: [1] Journal of Organic Chemistry, 2012, vol. 77, # 22, p. 10010 - 10020
[2] Angewandte Chemie - International Edition, 2016, vol. 55, # 5, p. 1872 - 1875[3] Angew. Chem., 2016, vol. 128, # 5, p. 1904 - 1907,4
[4] Patent: WO2017/51326, 2017, A1,
[5] Angewandte Chemie - International Edition, 2017, vol. 56, # 41, p. 12619 - 12623[6] Angew. Chem., 2017, vol. 129, # 41, p. 12793 - 12797,5
[7] Journal of the American Chemical Society, 2017, vol. 139, # 43, p. 15308 - 15311
[8] Organic Letters, 2018, vol. 20, # 11, p. 3296 - 3299
[9] Chemistry - A European Journal, 2018, vol. 24, # 37, p. 9269 - 9273
  • 4
  • [ 105-53-3 ]
  • [ 17435-72-2 ]
Reference: [1] Patent: EP729449, 2000, B1,
  • 5
  • [ 7789-60-8 ]
  • [ 17435-72-2 ]
Reference: [1] Patent: EP2316407, 2011, A1,
  • 6
  • [ 58539-11-0 ]
  • [ 17435-72-2 ]
Reference: [1] Journal of Organic Chemistry, 1955, vol. 20, p. 780,786
[2] Organic Syntheses, 1983, vol. 61, p. 77 - 77
  • 7
  • [ 64-17-5 ]
  • [ 20605-01-0 ]
  • [ 17435-72-2 ]
Reference: [1] Journal of Agricultural and Food Chemistry, 2011, vol. 59, # 21, p. 11718 - 11726
  • 8
  • [ 64-17-5 ]
  • [ 72707-66-5 ]
  • [ 17435-77-7 ]
  • [ 17435-72-2 ]
Reference: [1] Journal of the Chinese Chemical Society, 2008, vol. 55, # 2, p. 435 - 438
  • 9
  • [ 50-00-0 ]
  • [ 140-88-5 ]
  • [ 17435-72-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 4, p. 776 - 780
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 17435-72-2 ]

Alkenes

Chemical Structure| 4224-69-5

[ 4224-69-5 ]

Methyl 2-(bromomethyl)acrylate

Similarity: 0.94

Chemical Structure| 30982-08-2

[ 30982-08-2 ]

Methyl 2-(acetoxymethyl)acrylate

Similarity: 0.73

Chemical Structure| 10029-04-6

[ 10029-04-6 ]

Ethyl 2-(hydroxymethyl)acrylate

Similarity: 0.73

Chemical Structure| 3377-20-6

[ 3377-20-6 ]

Diethyl 2-methylenemalonate

Similarity: 0.71

Chemical Structure| 15484-46-5

[ 15484-46-5 ]

Methyl 2-(hydroxymethyl)acrylate

Similarity: 0.68

Aliphatic Chain Hydrocarbons

Chemical Structure| 4224-69-5

[ 4224-69-5 ]

Methyl 2-(bromomethyl)acrylate

Similarity: 0.94

Chemical Structure| 30982-08-2

[ 30982-08-2 ]

Methyl 2-(acetoxymethyl)acrylate

Similarity: 0.73

Chemical Structure| 10029-04-6

[ 10029-04-6 ]

Ethyl 2-(hydroxymethyl)acrylate

Similarity: 0.73

Chemical Structure| 539-74-2

[ 539-74-2 ]

Ethyl 3-bromopropanoate

Similarity: 0.71

Chemical Structure| 3377-20-6

[ 3377-20-6 ]

Diethyl 2-methylenemalonate

Similarity: 0.71

Bromides

Chemical Structure| 4224-69-5

[ 4224-69-5 ]

Methyl 2-(bromomethyl)acrylate

Similarity: 0.94

Chemical Structure| 61934-55-2

[ 61934-55-2 ]

4-(Bromomethyl)furan-2(5H)-one

Similarity: 0.80

Chemical Structure| 539-74-2

[ 539-74-2 ]

Ethyl 3-bromopropanoate

Similarity: 0.71

Chemical Structure| 3674-13-3

[ 3674-13-3 ]

Ethyl 2,3-Dibromopropionate

Similarity: 0.68

Chemical Structure| 3395-91-3

[ 3395-91-3 ]

Methyl 3-bromopropanoate

Similarity: 0.66

Esters

Chemical Structure| 4224-69-5

[ 4224-69-5 ]

Methyl 2-(bromomethyl)acrylate

Similarity: 0.94

Chemical Structure| 61934-55-2

[ 61934-55-2 ]

4-(Bromomethyl)furan-2(5H)-one

Similarity: 0.80

Chemical Structure| 30982-08-2

[ 30982-08-2 ]

Methyl 2-(acetoxymethyl)acrylate

Similarity: 0.73

Chemical Structure| 10029-04-6

[ 10029-04-6 ]

Ethyl 2-(hydroxymethyl)acrylate

Similarity: 0.73

Chemical Structure| 539-74-2

[ 539-74-2 ]

Ethyl 3-bromopropanoate

Similarity: 0.71